Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 5:17 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2857–2880 of 3,774 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Arm 3 intervention Clear all

Conditions: Peripheral Artery Disease
Interventions: Supervised Treadmill Exercise Therapy, Telmisartan, "No exercise" control group, Placebo; Behavioral · Drug · Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 114 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 3
States / cities: Chicago, Illinois • New Orleans, Louisiana

Conditions: Systemic Lupus Erythematosus, Rheumatoid Arthritis, Sharp's Syndrome
Interventions: Intravenous injection of Stromal Vascular Fraction Cells (SVF) containing ADSCs, Lipoaspiration; Other
Lead sponsor: Arkansas Heart Hospital; Other
Eligibility: 18 Years to 99 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Nicotine Use Disorder, Smoking Cessation, Smoking Cessation Intervention
Interventions: Enhanced Courage to Quit; Behavioral
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 26 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Diabetes Mellitus in Pregnancy
Interventions: SweetMama Focus Groups, SweetMama Individual Testing, SweetMama Feasibility Testing - Pilot Randomized Trial; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Inactivity, Physical
Interventions: Behavior Change Technique Package; Behavioral
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years to 85 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: New Hyde Park, New York

Conditions: Childhood Obesity
Interventions: Primary (Environmental) Weight Gain Prevention, Secondary (Behavioral) Weight Gain Prevention, Control; Behavioral
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: Not listed
Enrollment: 2,060 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Improving Cardiometabolic Outcomes in Older Adults
Interventions: Melatonin 1 mg, Placebos, Meal timing, Non-Meal timing; Dietary Supplement · Other
Lead sponsor: Northwestern University; Other
Eligibility: 55 Years to 75 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Aphasia, Primary Progressive
Interventions: Propranolol, Magnetic Resonance Imaging (MRI), Placebo; Drug · Device
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 50 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Adherence, Patient, HIV/AIDS, Group Meetings
Interventions: Sisters-GPS: Group Clinical Visits, Control: One-on-one Adherence Counseling; Behavioral
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Opioid-Related Disorders, Stimulant-Related Disorder, Child Neglect, Mental Health Impairment
Interventions: Prevention Adaptation of Families Actively Improving Relationships (PRE-FAIR), Standard Case Management and Referral; Behavioral
Lead sponsor: Chestnut Health Systems; Other
Eligibility: 16 Years to 30 Years
Enrollment: 241 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Eugene, Oregon

Conditions: Adenocarcinoma, Colorectal Cancer, Ovarian Cancer, Breast Cancer
Interventions: PANVAC-V, PANVAC-F, Sargramostim (GM-CSF, Leukine); Biological · Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 100 Years
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2018
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Suicide
Interventions: Coping Long Term with Active Suicide Program (CLASP); Behavioral
Lead sponsor: Brown University; Other
Eligibility: 18 Years and older
Enrollment: 850 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 7
States / cities: Little Rock, Arkansas • Boston, Massachusetts • Minneapolis, Minnesota + 4 more

Conditions: Sickle Cell Disease, Depression, Anxiety
Interventions: Computerized cognitive behavioral therapy; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Diffuse Large B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Double-Expressor Lymphoma, EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, High Grade B-Cell Lymphoma, Not Otherwise Specified, Neoplastic Cells With Double Expression of MYC and BCL2 Proteins Present, Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma
Interventions: Biospecimen Collection, Bone Marrow Biopsy, Computed Tomography, Cyclophosphamide, Doxorubicin Hydrochloride, Etoposide, Lumbar Puncture, Positron Emission Tomography, Prednisone, Rituximab, Venetoclax, Vincristine Sulfate; Procedure · Drug · Biological
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 80 Years
Enrollment: 363 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2028
U.S. locations: 634
States / cities: Birmingham, Alabama • Anchorage, Alaska • Fairbanks, Alaska + 433 more

Conditions: Parkinson Disease, Mild Cognitive Impairment
Interventions: Accelerated intermittent theta-burst stimulation (iTBS) rTMS to right superior parietal lobule (rSPL); Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 50 Years to 85 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Grief, Trauma, Psychotherapy, Critical Care
Interventions: EMPOWER, Supportive Conversation; Behavioral · Other
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 172 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 3
States / cities: Miami, Florida • New York, New York

Conditions: Toxicant Exposure, Firefighter, Occupational Exposure to Chemicals
Interventions: Colesevelam, Placebo; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older · Male only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Ventral Hernia
Interventions: Coaching, Constructive Feedback; Other
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 21 Years and older
Enrollment: 59 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Pediatric ALL, Infant Development, Neurodevelopmental Disorders
Interventions: PANDA Gym, Mobile App; Diagnostic Test · Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: 0 Months to 6 Months
Enrollment: 166 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Metastatic Uveal Melanoma, Metastatic Uveal Melanoma in the Liver
Interventions: Tebentafusp, TheraSphere™ Yttrium-90 Trans-Arterial Radioembolization; Drug · Radiation
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Rib Fractures, Pain, Acute
Interventions: Bright Blue Light, Bright Full-Spectrum (White) Light, Usual Ambient Light; Device
Lead sponsor: Rebecca E Kotcher, MD; Other
Eligibility: 18 Years and older
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: HPV-Related Oropharynx Squamous Cell Carcinoma
Interventions: Radiation therapy, Cisplatin, Surgery; Radiation · Drug · Procedure
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 142 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2033
U.S. locations: 3
States / cities: St Louis, Missouri • Fargo, North Dakota • Sioux Falls, South Dakota

Conditions: Lung Cancer
Interventions: CONNECT Intervention, CONTROL Group; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Diabetic Retinopathy, Diabetes Mellitus
Interventions: AI-BRIDGE, Educational Materials; Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 22 Years and older
Enrollment: 6,900 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Madison, Wisconsin

Search by objective public record fields.

Telmisartan Plus Exercise to Improve Functioning in Peripheral Artery Disease

Safety and Efficacy of Adipose Derived Stem Cells in Refractory Rheumatoid Arthritis, Systemic Lupus Erythematosus or Sharp's Syndrome

Implementation of Tobacco Cessation Programming at Community Behavioral Health Sites

SweetMama: Testing of a Novel Technology for Diabetes Education and Support to Pregnant Women

BCT Intervention For Walking Habit Among Caregivers of People With AD/ADRD

The Louisiana (LA) Health Project

Aging Program Project Grant 6

Propranolol in Primary Progressive Aphasia

Group Clinical Visit Adherence Intervention for HIV+ Women of Color

Preventing Parental Opioid and/or Methamphetamine Addiction Within DHS-Involved Families: PRE-FAIR

PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer

Veterans Coordinated Community Care (3C) Study

Cognitive Behavioral Therapy and Real-time Self-management Intervention for SCD Via Mobile Applications

Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas

Superior Parietal iTBS for PD-MCI

A Clinical Trial of Interventions to Support Family Surrogates of Critically Ill Patients

Examining a Novel Gastrointestinal Intervention to Negate Environmental Toxicants (ENGINE)

Video-based Collaborative Learning to Improve Ventral Hernia Repair

PANDA Gym: Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability

Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma

Blue Light as an Anti-inflammatory and Analgesic Strategy in Thoracic Trauma

The Minimalist Trial-2

Connect Oncology Needs Evaluation Tool

Leveraging Artificial Intelligence to Prevent Vision Loss From Diabetes